Large Volume Wearable Injectors Market

Global Large Volume Wearable Injectors Market Size (2024 to 2029)

The global large-volume wearable injectors market is estimated to register a CAGR of 4.6% from 2024 to 2029. As a result, the market size is anticipated to be USD 3.72 billion by 2029 from USD 2.97 billion in 2024.

Current Scenario of the Global Large Volume Wearable Injectors Market

Large-volume wearable injectors, a propelled rendition of the current self-infusion gadgets, are expected to receive enthusiasm from a broad client base. There are various such injectors financially accessible for the conveyance of insulin. OmniPod, from Insulet Corporation, is an exceptionally efficient gadget that has produced critical year-on-year income development. Notwithstanding, it merits featuring that, to date, just a single vast volume wearable injector (Smart Dose Electronic Wearable Injector) has been endorsed for the organization of a non-insulin biologic. Many organizations contribute their cash and assets to build these novel gadgets. Notwithstanding the publicly known projects, pharma organizations have numerous undisclosed projects that will give fundamental development a powerful force in the long haul.Numerous companies have been operating in this area in the last few years. Most of these are focused on the growth/commercialization of a diversity of wearable injectors. Such companies are significant for technological combination and source of devices and simplify clinical trials linked to drug-device combination products. It is believed that the device developers will continue to announce unique and user-friendly structures in their exclusive range of devices.

MARKET DRIVERS

The growing prevalence of chronic diseases such as diabetes and cancer is majorly propelling the large volume wearable injectors market growth.

The large volume of wearable injectors is much safer and more convenient than the traditional treatment, boosting the market growth. Furthermore, the convenience of the large volume of wearable injectors added an asset to the market. The advantages of large-volume wearable injectors, such as life cycle management and improved compliance, boost the market growth. Furthermore, as a consequence of over a decade of extensive R&D, large-volume wearable injectors offer a safe and convenient (permitting self-medication) solution to patients who suffer from chronic diseases and are required to medicate frequently, which is expected to add fuel to the market growth. Considering the rise in efforts to improve drug delivery and the ongoing research pace in the medical devices industry, the large volume wearable injectors market is likely to showcase a healthy CAGR during the forecast period. In addition, upgrading current devices to more capable/next-generation devices will aid as a key driver of instant near-term growth.

MARKET RESTRAINTS

The lack of self-awareness in emerging countries on Wearable Injectors is the major restrain of the market. The countries such as India and China are not providing reimbursement for wearable injectors, hindering market growth. Moreover, the strict government policies on wearable injectors are hampering the market.  The patient's lack of trust in prescribed medication is the major challenge for the Large Volume Wearable Injectors Market. According to a study, Children and Older people misuse medicine, which is a significant drawback for the market.

Covid-19 Impact On The Global Large-volume Wearable Injectors Market

COVID-19 has affected all sectors differently, either positively or negatively. COVID-19 is a pandemic declared by WHO. Governments have imposed lockdown guidelines to control the spread of the novel coronavirus disease. The large volume wearable injectors market has pushed its market during the pandemic. Due to the coronavirus, patients suffering from chronic diseases started using remote care technologies like wearable injections. Furthermore, the market has had some rough times due to a lack of production, and there is no supply for the demand due to restrictions on the movement. But the key players in the Large Volume Wearable Injectors Market have announced new technologies and devices to sustain the market.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global Large Volume Wearable Injectors Market Analysis By Wearable Injector Type

Based on wearable injector type, the On-Body (Adhesive Patch) segment had the largest share of 55.7% in 2022 and is expected to grow at a healthy CAGR during the forecast period. The on-body segment was very comfortable to wear on the skin, especially on the stomach, which led the market to grow. Moreover, they were also water-resistant and comfortable to use at home.The off-body (belt clip) segment is expected to grow gradually during the forecast period owing to the growing investments in remote device developments. It is expected to introduce many new products.

Global Large Volume Wearable Injectors Market Analysis  By Therapeutic Area

Based on the therapeutic area, the oncology segment dominated the market with a share of 29.9% in 2022. The segment is expected to grow significantly during the forecast period owing to the rise in cancer patients and the increase in self-administration adoption.On the other hand, the auto-immune disorders segment is estimated to grow at a healthy CAGR over the forecast period. The rise in diabetes and the adoption of wearable injectors are boosting the segment’s growth.

Global Large Volume Wearable Injectors Market  Analysis  By Mechanism of Injection

Based on the injection mechanism, the spring-based expanding battery segment occupied 36.3% of the global large-volume wearable infectors market in 2022. The spring-based expanding battery devices are user-friendly, and it perfectly delivers the drug subcutaneously by pressing a button, which led the market to grow humongous.The motor-driven segment is one of the fastest-growing segments in the global large-volume wearable injectors market and is expected to progress well during the forecast period.

Global Large Volume Wearable Injectors Market Analysis  By Usage

Based on the usage, the disposable segment is gaining traction. It is anticipated to grow at a significant CAGR during the forecast period owing to the increasing demand to curb the transmission of infectious diseases. In addition, the semi-reusable segment is estimated to hit a considerable CAGR in the foreseen years. 

Global Large Volume Wearable Injectors Market Analysis  By Application

Based on application, the home care settings segment is predicted to dominate the market with the highest CAGR during the forecast period. The segment's growth is driven by the growing adoption of the self-administration of medicine, the rise in technological drug delivery, and the low cost associated with self-adhesive devices.

REGIONAL ANALYSIS

Geographically, the North 1American region had the highest share of the global market in 2022, and it is estimated to grow at an impressive CAGR during the forecast period. The market participants are developing innovative ways to help people suffering from diseases that need continuous or frequent treatment. Furthermore, developing countries such as U.S. and Canada, the North American countries, are contributing significantly to this region and helping the region to register the lead. In addition, the growing efforts of R&D and government policies are further propelling the North American large-volume wearable injectors market.

The European large-volume wearable injectors market is the second biggest market in terms of market share globally. Europe is assumed to grow rapidly during the forecast period. The enhanced product efficacy in long-term dosage and rising chronic diseases are the reasons for the market growth. Moreover, government policies and reimbursements are boosting Europe's large volume of wearable injectors market.

The Asia Pacific large-volume wearable injectors market is estimated to grow at a significant CAGR during the forecast period. An increase in diabetic patients in heavily populated countries like India and the adoption of wearable injectors for chronic diseases is fuelling the growth of the regional market. India, China, and Japan are the major contributors to the Asia-Pacific market. In addition, growing requirements for low, minimum, and painless devices, as increasing cardiovascular, diabetes, and cancer diseases, fuel the large volume wearable injectors market in the Asia Pacific.

The Latin America large volume wearable injectors market is anticipated to grow steadily during the forecast period.

The large volume wearable injectors market in the Middle East and Africa is estimated to grow at a sluggish CAGR in the coming years.

KEY PLAYERS IN THE GLOBAL LARGE VOLUME WEARABLE INJECTORS MARKET

Companies leading the global large-volume wearable injectors market profiled in this report are Ypsomed AG, West Pharmaceutical Services Inc., Sensile Medical AG, Becton Dickinson and Company, Amgen Inc., Enable Injections Inc., Unilife Corporation, and Insulet Corporation. Many companies have undertaken initiatives to develop drug-delivery devices that allow self-medication, even for biologics beyond insulin. Companies focused on developing devices for insulin delivery have already established strong brand positions in this domain, with injectors equipped with insulin monitoring and data connectivity.

DETAILED SEGMENTATION OF GLOBAL MEDICAL LARGE VOLUME WEARABLE INJECTORS MARKET INCLUDED IN THIS REPORT
 

This research report on the global large-volume wearable injectors market has been segmented and sub-segmented based on the application, wearable injector type, therapeutic area, injection mechanism, usage, and region.

By Wearable Injector Type

• Hand-Held
• Off-Body (Belt Clip)
• On-Body (Adhesive Patch)

By Therapeutic Area

• Infectious Diseases
• Diabetes
• Oncology
• Cardiovascular
• Auto-Immune Disorders
• Others

By Mechanism of Injection

• Collapsible Reservoir Rotary Pump
• Spring-Based Expanding Battery
• Motor-Driven
• Pressurized Gas

By Usage

• Semi-Reusable
• Disposable

 By Application

• Hospitals
• Ambulatory Surgery Centers
• Home Care Settings
• Clinics
• Others

By Region

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa